Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trial
Author:
Publisher
Elsevier BV
Subject
Clinical Neurology
Reference17 articles.
1. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria;Polman;Ann Neurol,2011
2. Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study;Comi;Lancet,2001
3. Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial;Comi;Lancet,2009
4. Comparison of two dosing frequencies of subcutaneous interferon beta-1a in patients with a first clinical demyelinating event suggestive of multiple sclerosis (REFLEX): a phase 3 randomised controlled trial;Comi;Lancet Neurol,2012
5. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group;Jacobs;N Engl J Med,2000
Cited by 207 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cladribine use trend in Latin America: the changes in patient profile impact in the drug effectiveness;Neurological Sciences;2024-09-11
2. Experience with the use of cladribine tablets in real-life clinical practice: independent analysis of data from 12 Russian clinical centres;Neurology, Neuropsychiatry, Psychosomatics;2024-08-07
3. Real-world effectiveness of cladribine as an escalation strategy for MS: Insights from the Czech nationwide ReMuS registry;Journal of Central Nervous System Disease;2024-07-24
4. Cladribine effects on patient-reported outcomes and their clinical and biometric correlates in highly active relapsing multiple sclerosis at first switch: the observational, multicenter, prospective, phase IV CLADFIT-MS study;Frontiers in Neurology;2024-07-18
5. Experience of cladribine tablets usage in the treatment of multiple sclerosis in the Multiple Sclerosis Centre of the Khanty-Mansi Autonomous Area — Yugra;Neurology, Neuropsychiatry, Psychosomatics;2024-06-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3